|[February 07, 2014]
Research and Markets: 2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostics Market
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/jv62hd/2014_strategies)
has announced the addition of the "2014
Strategies for the Italian Clinical Chemistry and Immunodiagnostics
Market" report to their offering.
2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostic
Market is a new strategic analysis of major business opportunities
emerging in the Italian clinical chemistry and immunodiagnostic markets
during the next five years. The report explores future trends in the
German market; provides estimates of the specimen, test and sales
volumes, as well as major suppliers' sales and market shares; compares
features of leading analyzers; profiles key competitors; and identifies
specific product and marketing opportunities emerging during the next
The report provides five-year volume and sales forecasts for over 100
clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused
drug assays performed in hospitals, commercial laboratories, physician
offices, and ambulatory care centers, including controls, calibrators
The clinical chemistry and immunodiagnostic markets are undergoing
significant transformation, caused by convergence of new and more
stringent regulations; advances in diagnostic technologies, system
engineering, automation, and IT; and intensifying competition. Some
segments, like routine chemistry, are already resembling commodity
markets, where product positioning and cost per test are more critical
than underlying technology. This evolving marketplace creates exciting
opportunities for a variety of new instruments, reagent systems, and
auxiliary products, such as specimen preparation devices, controls, and
New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics,
collaborative arrangements and new products in R&D.
The companies analyzed in the report include Abbott, AdnaGen, Agilent (News - Alert),
Alere, Beckman Coulter/Danaher, Biomedical Diagnostics, bioMerieux,
Bio-Rad, DiaSorin, Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex,
Ortho-Clinical Diagnotics, Roche, Siemens (News - Alert), Sysmex, Thermo Fisher,
Tosoh, Wako, Wallac/PE.
For more information visit http://www.researchandmarkets.com/research/jv62hd/2014_strategies
[ Back To TMCnet.com's Homepage ]